The addition of anthracyclines to adjuvant taxane-based chemotherapy improved survival for certain high-risk patients with ...
Biopharma executives shared their thoughts on the potential impacts of the new administration; Annalee Armstrong recaps JPM ...
The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...
T-DXd outperformed physician’s choice of chemotherapy regardless of patients’ disease burden or time to progression on prior therapy.
The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...
On Friday, the U.S. Food and Drug Administration (FDA) approved AstraZeneca Plc’s (NASDAQ:AZN) Datroway (datopotamab ...
CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).
As more Asia biotechs turn to regenerative medicine to address disorders without a cure, Medipost Inc. is continuing global expansion with Cartistem, its allogeneic human umbilical cord blood-derived ...
The current price of Dai (DAI) is $0.999927, as of January 20, 2025. Over the last 24 hours, the price has moved by -0.01%, with a change of 0.01% in the past hour. For longer-term performance, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback